Earnings Week Puts Jabil and CarMax in the Spotlight
A busy earnings slate spans biotech, publishing, used autos, manufacturing, grocery, and consulting. Jabil enters at a 52-week high, CarMax has rebounded sharply, and Accenture still trades below its long-term average, setting up potentially volatile reactions to even small surprises.
This earnings week features a wide mix of names, but the real market story is price sensitivity: several stocks are reporting after sharp moves versus their 50-day and 200-day averages. That setup means even modest beats or misses could trigger outsized share-price reactions, with Jabil, CarMax, Accenture and Kroger drawing the most attention from investors.
This earnings week lines up a useful cross-section of the market: consulting, manufacturing, used autos, publishing, grocery, and biotech. The common thread is simple. Several stocks are entering their reports after sharp moves versus their 50-day or 200-day averages, which raises the odds that even small earnings surprises can hit share prices hard.
Key Takeaways
Regencell Bioscience Holdings Limited (RGC) reports first on June 15, with the stock down 4.37% on the day and analysts at Hold.
John Wiley & Sons (WLY), CarMax (KMX), and Jabil (JBL) all report on June 16 or June 17, and each beat earnings estimates in their most recent quarter.
Accenture (ACN) and Kroger (KR) report on June 18, giving the week two large-cap readouts from technology services and consumer staples.
Recent price action is split. Jabil (JBL) sits at a 52-week high, while Accenture (ACN) still trades well below its 200-day average.
Analyst sentiment leans constructive on most names in focus, with Buy consensus ratings on Accenture (ACN), Jabil (JBL), Kroger (KR), and Korn Ferry (KFY).
Regencell Bioscience Holdings Limited (RGC): Volatility Arrives First
Regencell Bioscience Holdings Limited (RGC) is scheduled to report on June 15. The stock closed at $18.83 after a 4.37% daily drop, and that pullback adds to a wide 52-week range of $9.39 to $83.60. In other words, this is not a calm setup.
Analyst sentiment is restrained. RGC carries a Hold consensus, with 4 Hold ratings and no Buy or Sell ratings in the current tally. That neutral stance matters because the company is still posting negative trailing EPS of -$0.01, leaving little room for sloppy execution in a stock that already trades with a beta of 1.639.
Unlike several other names on this week’s calendar, there is no recent earnings surprise data listed here for RGC. What is concrete is the stock’s trading behavior. Shares sit below both the 50-day average of $26.765 and the 200-day average of $22.4267. That combination often tells the same story in plain English: momentum has cooled, and confidence has not rebuilt yet.
For the week ahead, RGC stands out less for broad analyst support and more for price sensitivity. When a healthcare name with a $9.31B market cap swings inside such a large annual range, earnings can act like a stress test for sentiment.
John Wiley & Sons (WLY): A Quiet Stock Near a 52-Week High
John Wiley & Sons (WLY) reports on June 16. The stock closed at $44.17 after slipping 1.08% on the day, yet the bigger picture is still constructive. Shares remain above the 50-day average of $41.3696 and the 200-day average of $36.35055, while the 52-week high sits at $45.64.
That price pattern gives WLY a steadier look than many small and mid-cap earnings names. It is not a momentum rocket, but it has climbed from a 52-week low of $28.38 to trade near the top of its range. Sometimes the market rewards boring consistency. Sometimes it punishes it for not being exciting enough. Earnings week tends to settle that debate fast.
Analyst sentiment is modest, with a Hold consensus built from 1 Buy and 2 Hold ratings. The latest earnings history is better than that muted rating implies. On March 5, 2026, WLY posted actual EPS of $0.97 versus an estimate of $0.86. That beat gives the company at least some recent credibility heading into this report.
Wiley operates in Publishing within Communication Services, which makes it one of the more defensive names on this list. With trailing EPS at $2.86 and a P/E of 15.44, the stock does not carry the kind of valuation that usually forgives a stumble. Still, the recent earnings beat and firm trend above long-term averages keep WLY relevant this week.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
CarMax (KMX): Strong Recovery Meets a Skeptical Rating
CarMax (KMX) is set to report on June 17. The stock closed at $51.26, down 0.60% on the day, but that small dip hides a much stronger rebound. Shares now sit well above the 50-day average of $41.711 and the 200-day average of $43.68805 after trading as low as $30.26 over the past year.
That recovery matters because KMX still carries a Hold consensus from 1 Strong Buy, 9 Buy, 21 Hold, and 4 Sell ratings. In short, the stock has climbed faster than analyst enthusiasm. That mismatch can create a sharp reaction window around earnings, especially when sentiment is cautious but price action has already improved.
The latest earnings result was solid. On April 14, 2026, CarMax posted actual EPS of $0.34 versus an estimate of $0.2283. Beating by that margin gave the company a cleaner setup than the stock had for much of last year. It also reinforced that the market’s view of used auto retail can change quickly when execution firms up.
CarMax operates in Auto Dealerships within Consumer Cyclical, so the stock often trades at the intersection of consumer demand and financing conditions. The trailing EPS is $1.68 and the P/E is 30.51, which is not cheap for a retailer. Therefore, this report matters because the stock has already earned back a lot of ground.
Jabil (JBL): Momentum Name Enters Earnings at a 52-Week High
Jabil (JBL) reports on June 17, and few stocks on this calendar bring stronger price momentum. Shares closed at $384.85 after rising 2.11% on the day, and that finish matched a fresh 52-week high of $386.64. The stock also stands far above its 50-day average of $338.1502 and 200-day average of $256.42456.
That kind of chart usually means expectations are no longer modest. JBL carries a Buy consensus, with 1 Strong Buy, 11 Buy, and 11 Hold ratings. The split between Buy and Hold is worth noting. Analysts are constructive, but not blindly so, which is often the right posture when a stock has already doubled from its 52-week low of $175.08.
The company also has recent earnings momentum. On March 18, 2026, Jabil posted actual EPS of $2.69 versus an estimate of $2.51. That beat helped support the rally and reinforced the stock’s leadership within Hardware, Equipment & Parts.
Valuation is the one area that looks less forgiving. JBL trades at a trailing P/E of 51.87 on EPS of $7.42. When a manufacturing and hardware stock carries that multiple while sitting at a 52-week high, the next report has less room for error. This is the classic strong-stock problem: great momentum, but a tougher bar.
Accenture (ACN): A Large-Cap Tech Services Checkpoint
Accenture (ACN) is scheduled to report on June 18. The stock closed at $170.28 after a 1.65% gain on the day, but the broader trend still looks mixed. Shares remain below the 50-day average of $181.3326 and well below the 200-day average of $228.18, even though they are above the 52-week low of $155.82.
That backdrop makes ACN one of the more interesting large-cap setups of the week. The stock has not reclaimed its longer-term trend, yet analyst sentiment remains favorable. Accenture carries a Buy consensus with 37 Buy ratings, 15 Hold ratings, and just 1 Sell rating.
Recent earnings execution has also been solid. On March 19, 2026, Accenture posted actual EPS of $2.93 versus an estimate of $2.84. That beat did not erase the stock’s larger decline from the 52-week high of $317.05, but it did show that the business is still delivering enough to top estimates.
As a global leader in Information Technology Services, ACN often functions like a read-through on enterprise spending discipline. The trailing EPS is $12.20 and the P/E is 13.96, which is far less stretched than many technology names. Therefore, this report lands in a useful middle ground: a major tech services company, a discounted chart versus long-term averages, and a still-positive analyst base.
The Kroger Co. (KR): Defensive Name, Modest Trend, Recent Beat
The Kroger Co. (KR) also reports on June 18. Shares closed at $64.71 after a 0.92% daily gain. Unlike Jabil or CarMax, KR is not coming into earnings with a dramatic trend. The stock sits slightly below both its 50-day average of $66.5874 and 200-day average of $66.5923, while remaining above the 52-week low of $58.60.
That flatter setup fits the business. Kroger operates in Grocery Stores within Consumer Defensive, and defensive stocks often trade with less drama until earnings force a repricing. Analyst sentiment still leans constructive, with a Buy consensus made up of 21 Buy, 17 Hold, and 6 Sell ratings.
The latest quarter gave bulls a useful data point. On March 5, 2026, KR posted actual EPS of $1.28 versus an estimate of $1.20. That beat matters because it came from a company with a low beta of 0.416, where steady execution often carries more weight than flashy narratives.
Kroger’s trailing EPS is $1.54 and the stock trades at a P/E of 42.02. That multiple looks high for a grocery chain, which means the market has already assigned value to resilience. As a result, this report matters not because KR is a thrill ride, but because defensive names still need to justify their premium when the tape gets selective.
Like what you're reading?
Get full access to AI-powered research reports, market analysis, and portfolio tools.
Korn Ferry (KFY): A Late-Week Read on Hiring Demand
Korn Ferry (KFY) reports on June 24, making it the last major name in this focus group. The stock closed at $73.22, essentially flat on the day, and it continues to hold above both its 50-day average of $67.103 and 200-day average of $67.0367. Shares also sit close to the 52-week high of $78.50.
That is a healthy setup for a staffing and organizational advisory company. KFY carries a Buy consensus with 6 Buy and 5 Hold ratings. It also posted a recent earnings beat, with actual EPS of $1.28 on March 9, 2026 versus an estimate of $1.22.
Because Korn Ferry operates in Staffing & Employment Services, the stock often serves as a practical check on corporate hiring appetite. The trailing EPS is $5.04 and the P/E is 14.53, which is a more grounded valuation than many momentum names. That combination of solid trend, recent beat, and moderate multiple gives KFY a cleaner setup than the average small-cap earnings story.
Other Earnings to Watch
WLYB (John Wiley & Sons B) , Communication Services / Publishing, reports 2026-06-16 bmo.
The upcoming earnings week is less about one headline giant and more about how different corners of the market are pricing execution. Jabil (JBL) and CarMax (KMX) bring momentum, Accenture (ACN) and Kroger (KR) bring sector read-throughs, and names like Wiley (WLY) and Korn Ferry (KFY) offer quieter but still useful signals. When stocks enter reports from such different technical positions, earnings do not just confirm results. They reset the map.
▌Common Questions
Frequently asked questions
+Which stocks are the main earnings reports to watch this week?
The key reports this week include Regencell Bioscience, John Wiley & Sons, CarMax, Jabil, Accenture and Kroger. Jabil and CarMax are especially important because both have recent price momentum that could amplify the market reaction.
+Why could earnings reactions be bigger than usual this week?
Several companies are entering earnings after trading far above or below their 50-day and 200-day moving averages. When a stock is already stretched, even a small earnings surprise can move shares sharply.
+Is Jabil still a stock investors should watch closely before earnings?
Yes, Jabil is one of the most important names on the calendar because it is trading near a 52-week high. That makes the stock vulnerable to a strong reaction if results or guidance disappoint.
+What makes CarMax an important earnings report this week?
CarMax has staged a strong recovery above both its 50-day and 200-day averages, but analyst sentiment remains only cautious. That gap between improving price action and mixed ratings makes the report a key test for the stock.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
